🔗 Visit the ClinicalTrials.gov page for NCT01191190
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia. | Leukemia | 2009 | 1.30 |
| 2 | Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia. | Leukemia | 2008 | 1.27 |
| 3 | Role of ofatumumab in treatment of chronic lymphocytic leukemia. | J Blood Med | 2011 | 0.76 |